NTMed

Company Overview

Snapshot

Founded in January 2020 by Valery Diamant, Marat Lerner, and Gideon Meiry, NTMed operates with 1–10 employees. The company has raised $800,000 across one funding round, focusing on developing advanced wound healing solutions.

Business overview

NTMed is a Health Tech & Life Sciences company specializing in the development of novel materials for chronic wound healing. The company's core technology integrates electrical exogenous stimulus with antimicrobial efficacy to enhance healing processes and tissue regeneration. NTMed targets the healthcare and life sciences industries, particularly focusing on pharmaceuticals and biomaterials, to address the significant costs and challenges associated with non-healing wounds like surgical wounds and diabetic ulcers.

Company Intelligence Q&A

When was NTMed founded?

NTMed was founded in January 2020 by Valery Diamant, Marat Lerner, and Gideon Meiry.

What is NTMed's primary focus?

NTMed is focused on developing advanced materials that combine electrical stimulation with antimicrobial properties to enhance wound healing and regenerative processes, particularly for chronic, non-healing wounds.

How much funding has NTMed raised?

NTMed has raised a total of $800,000 across one seed funding round, which occurred in January 2020.

What is the employee count for NTMed?

NTMed currently has 1–10 employees.

What markets does NTMed serve?

NTMed serves the global market, with a focus on the healthcare and life sciences sectors, including pharmaceuticals.